J2KBIO Co., Ltd.
J2KBIO Co., Ltd., a bio venture company, offers active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.
J2KBIO Co., Ltd. (420570) - Total Assets
Latest total assets as of September 2025: ₩37.63 Billion KRW
Based on the latest financial reports, J2KBIO Co., Ltd. (420570) holds total assets worth ₩37.63 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
J2KBIO Co., Ltd. - Total Assets Trend (2021–2024)
This chart illustrates how J2KBIO Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
J2KBIO Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
J2KBIO Co., Ltd.'s total assets of ₩37.63 Billion consist of 55.1% current assets and 45.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 19.3% |
| Accounts Receivable | ₩3.58 Billion | 9.9% |
| Inventory | ₩2.69 Billion | 7.5% |
| Property, Plant & Equipment | ₩15.00 Billion | 41.7% |
| Intangible Assets | ₩417.07 Million | 1.2% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how J2KBIO Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: J2KBIO Co., Ltd.'s current assets represent 55.1% of total assets in 2024, an increase from 54.6% in 2021.
- Cash Position: Cash and equivalents constituted 19.3% of total assets in 2024, down from 27.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is property, plant & equipment at 41.7% of total assets.
J2KBIO Co., Ltd. Competitors by Total Assets
Key competitors of J2KBIO Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel N.V
OTCQX:AKZOF
|
USA | $13.95 Billion |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩51.65 Billion |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥2.55 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
DL Holdings CO. LTD.
KO:000210
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
J2KBIO Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - J2KBIO Co., Ltd. generates 0.92x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - J2KBIO Co., Ltd. is currently not profitable relative to its asset base.
J2KBIO Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.19 | 6.96 | 6.45 |
| Quick Ratio | 5.20 | 5.97 | 5.65 |
| Cash Ratio | 0.00 | 0.00 | 1.34 |
| Working Capital | ₩17.83 Billion | ₩ 16.72 Billion | ₩ 20.43 Billion |
J2KBIO Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between J2KBIO Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.37 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 63.4% |
| Total Assets | ₩35.97 Billion |
| Market Capitalization | $11.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values J2KBIO Co., Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: J2KBIO Co., Ltd.'s assets grew by 63.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for J2KBIO Co., Ltd. (2021–2024)
The table below shows the annual total assets of J2KBIO Co., Ltd. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩35.97 Billion | +63.37% |
| 2023-12-31 | ₩22.02 Billion | +24.99% |
| 2022-12-31 | ₩17.61 Billion | +9.06% |
| 2021-12-31 | ₩16.15 Billion | -- |